1. Li, Can, Ge, Shanghua, Zhou, Jialu, Deng, Libin, Tang, Xiaoli. 2020. Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma. In PloS one, 15, e0234062. doi:10.1371/journal.pone.0234062. https://pubmed.ncbi.nlm.nih.gov/32497093/
2. Lu, Jianglong, Li, Qun, Cai, Lin, Su, Zhipeng, Wang, Chengde. 2018. RBM17 controls apoptosis and proliferation to promote Glioma progression. In Biochemical and biophysical research communications, 505, 20-28. doi:10.1016/j.bbrc.2018.09.056. https://pubmed.ncbi.nlm.nih.gov/30227940/
3. Fukumura, Kazuhiro, Venables, Julian P, Mayeda, Akila. 2021. SPF45/RBM17-dependent splicing and multidrug resistance to cancer chemotherapy. In Molecular & cellular oncology, 8, 1996318. doi:10.1080/23723556.2021.1996318. https://pubmed.ncbi.nlm.nih.gov/35419480/
4. Nagamine, Hiroaki, Yashiro, Masakazu, Yoshimoto, Naoki, Mayeda, Akila, Kawaguchi, Tomoya. . RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression. In Anticancer research, 43, 4663-4672. doi:10.21873/anticanres.16662. https://pubmed.ncbi.nlm.nih.gov/37772582/
5. Fu, Yan, Bai, Chen, Wang, Shengsheng, Chen, Shaojuan, Wang, Zhenjun. . AKT1 phosphorylates RBM17 to promote Sox2 transcription by modulating alternative splicing of FOXM1 to enhance cancer stem cell properties in colorectal cancer cells. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 37, e22707. doi:10.1096/fj.202201255R. https://pubmed.ncbi.nlm.nih.gov/36520054/
智鼠故事 
